he was President and Board Director of Alpine Immune Sciences, which he co-founded as a Managing Partner of Alpine BioVentures. Alpine Immune Sciences was acquired by Vertex Pharmaceuticals for $4 ...

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals ... Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...

Atea Pharmaceuticals (AVIR) announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors. Kirsch is currently a Senior ...

Canada Pension Plan Investment Board raised its holdings in Vertex Pharmaceuticals by 30.1% in the fourth quarter. Canada Pension Plan Investment Board now owns 369,354 shares of the ...

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals ... Kirsch to the Company's Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking ...

Atea Pharmaceuticals has appointed Arthur S. Kirsch to its Board of Directors, effective immediately. Kirsch brings over 30 years of experience in investment banking and capital markets ...

Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals ... a seasoned biotechnology executive and board director, to the Company’s Board of Directors, effective immediately.

Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns” or the "Company ... a seasoned biotechnology executive and board director, to the Company's Board of Directors, effective ...

Pain, as Vertex Pharmaceuticals found out ... a “glaring” outcome for Richard Vaglienti, medical director of the Center for Integrative Pain Management at West Virginia University, which ...